General MedicationsORALGeneric
WINSTROL
STANOZOLOL
Standard Dose
2MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview WINSTROL is listed in Drugs@FDA under application 012885 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient STANOZOLOL Form and strength TABLET;ORAL - 2MG Sponsor LUNDBECK INC Submission history Latest submission status date: 2003-11-17 00:00:00.
Structured Monograph
Clinical summary
Approval overview WINSTROL is listed in Drugs@FDA under application 012885 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient STANOZOLOL Form and strength TABLET;ORAL - 2MG Sponsor LUNDBECK INC Submission history Latest submission status date: 2003-11-17 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.